000 | 01987 a2200517 4500 | ||
---|---|---|---|
005 | 20250515072035.0 | ||
264 | 0 | _c20070817 | |
008 | 200708s 0 0 eng d | ||
022 | _a0953-816X | ||
024 | 7 |
_a10.1111/j.1460-9568.2007.05576.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTang, Qingbo | |
245 | 0 | 0 |
_aInhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation. _h[electronic resource] |
260 |
_bThe European journal of neuroscience _cMay 2007 |
||
300 |
_a2964-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAmidines _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzylamines _xpharmacology |
650 | 0 | 4 |
_aCarrageenan _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aHyperalgesia _xdrug therapy |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 |
_aInflammation Mediators _xpharmacology |
650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeurons, Afferent _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xantagonists & inhibitors |
650 | 0 | 4 |
_aNociceptors _xdrug effects |
650 | 0 | 4 | _aPain Measurement |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
700 | 1 | _aSvensson, Camilla I | |
700 | 1 | _aFitzsimmons, Bethany | |
700 | 1 | _aWebb, Michael | |
700 | 1 | _aYaksh, Tony L | |
700 | 1 | _aHua, Xiao-Ying | |
773 | 0 |
_tThe European journal of neuroscience _gvol. 25 _gno. 10 _gp. 2964-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1460-9568.2007.05576.x _zAvailable from publisher's website |
999 |
_c17100269 _d17100269 |